Hudson Executive Capital LP, Director, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 13,842 shares at $62.58 ($866K) on 2019-10-17, disclosed to the SEC on 2019-10-18.
Open-market sale of $866k EGRX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CATM | BUY | 2020-06-29 | $8.6M | — | Filing → |
| CATM | BUY | 2020-06-23 | $8.2M | — | Filing → |
| CATM | BUY | 2020-05-19 | $1.5M | — | Filing → |